Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations

European Journal of Pediatrics

Volumn 166, Issue 6, 2007, Pages 585-588

  Zipitis, Christos S ^a,b   Thalange, Nandu ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Immunoglobulins; Mycoplasma infection; Stevens Johnson syndrome; Treatment

Indexed keywords

ACICLOVIR; ANALGESIC AGENT; C REACTIVE PROTEIN; CHLORAMPHENICOL; CLARITHROMYCIN; COLD AGGLUTININ; HYALURONIDASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; INFUSION FLUID; LOCAL ANESTHETIC AGENT; MACROLIDE;

ADOLESCENT; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CASE REPORT; COMPLEMENT FIXATION; CONVALESCENCE; COUGHING; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DRUG MEGADOSE; DYSURIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EROSION; FEVER; HEMORRHAGIC CONJUNCTIVITIS; HUMAN; HYDRATION; HYPERSALIVATION; LIP; MALE; MOUTH HYGIENE; MOUTH ULCER; MYCOPLASMA; MYCOPLASMA PNEUMONIAE; PERIORBITAL EDEMA; PRIORITY JOURNAL; SCROTUM; SKIN MANIFESTATION; SPUTUM; STEVENS JOHNSON SYNDROME; SWELLING; TREATMENT OUTCOME;

ADOLESCENT; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MYCOPLASMA PNEUMONIAE; STEVENS-JOHNSON SYNDROME;

EID: 34247375533     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0287-9     Document Type: Article

References (28)

1. Arca E, Kose O, Erbil AH, Nisanci M, Akar A, Gur AR (2005) A 2-year-old girl with Stevens-Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin. Pediatr Dermatol 22(4):317-320
2. Amato GM, Travia A, Ziino O (1992) The use of intravenous high-dose immunoglobulins (IVIG) in a case of Stevens-Johnson syndrome. Pediatr Med Chir 14:555-556
3. Bachot N, Revuz J, Roujeau JC (2003) Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 139:33-36
4. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92-96
5. Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, Walker AM (1990) The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: a population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 126:43-47
6. Dibirdik I, Durak N, Kislaoglu E, Kutluay T, Aytemiz C (1995) Effects of prophylactic intravenous immunoglobulin-G therapy on humoral and cellular immune components and their functions in burned patients. Burns 21:130-135
7. Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT (1986) Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 204(5):503-512
8. Kazatchkine MD, Kavert SV (2001) Immunomodulation of autoimmune and inflammatory disease with intravenous immune globulin. N Engl J Med 345:747-755
9. Leaute-Labreze C, Lamireau T, Chawki D, Maleville J, Taieb A (2000) Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 83 (4):347-352
10. Levy M, Shear NH (1991) Mycoplasma pneumoniae infections and Stevens-Johnson syndrome. Report of eight cases and review of the literature. Clin Pediatr (Phila) 30(1):42-49
11. Merlin E, Al Fatuhi H, Crost P (2004) Kawasaki syndrome and Mycoplasma pneumoniae infection. Arch Pediatr 11(8):972-973
12. Metry DW, Jung P, Levy ML (2003) Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatr 112:1430-1436
13. Morici MV, Galen WK, Shetty AK, Lebouef RP, Gouri TP, Cowan GS, Gedalia A (2000) Intravenous immunoglobulin therapy for children with Stevens-Johnson syndrome. J Rheumatol 27(10):2494-2497
14. Patterson R, Miller M, Kaplan M, Doan T, Brown J, Detjen P, Grammer LC, Greeberger PA, Hogan MB, Latall J (1994) Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy 73(1):27-34
15. Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I, Mauri DN, Flynn K, Trent J, Margolis DJ, Saurat JH, French LE (2003) Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 139:26-32
16. Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J, Touraine R (1987) Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Arch Dermatol 123:1160-1165
17. Roujeau JC, Ster RS (1994) Severe adverse cutaneous reactions to drugs. N Engl J Med 331(19):1272-1285
18. Rzany B, Schmitt H, Schopf E (1991) Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Derm Venereol Suppl (Stockh) 71:171-172
19. Schalock PC, Dinulos JG (2005) Mycoplasma pnemoniaeinduced Stevens-Johnson syndrome without skin lesions: fact or fiction? J Am Acad Dermatol 52(2):312-315
20. Sheretz EF, Jegasothy BV, Lazarus GS (1985) Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis: report of a patient treated with corticosteroid "pulse therapy." J Am Acad Dermatol 12:178-181
21. Stevens AM, Johnson FC (1992) A new eruptive fever associated with stomatitis and opthalmia. Am J Dis Child 24:526-533
22. Trent JT, Kirsner RS, Romanelli P, Kerdel FA (2003) Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: the University of Miami experience. Arch Dermatol 139:33-36
23. Tristani-Firouzi P, Petersen MJ, Saffle JR, Morris SE, Zone JJ (2002) Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 47(4):548-552
24. Vanfleteren I, Van Gysel D, De Brandt C (2003) Stevens-Johnson syndrome: a diagnostic challenge in the absence of skin lesions. Pediatr Dermatol 20(1):52-56
25. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282:490-493
26. Weston WL, Oranje AP, Rasmussen JE, Yamamoto K, Honig PJ, Saurat JH, Salomon D, Ruizmaldonado R, Hurwitz S, Prose NS, Krafchik BR, Levy ML, Weinberg S, Raimer SS, Wiss K, Atherton DJ, Hansen RC (1989) Corticosteroids for erythema multiforme? Pediatr Dermatol 6:229-250
27. Wilkins J, Morrison L, White CR Jr (1992) Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson/toxic epidermal necrolysis spectrum. Dermatol Clin 10:571-582
28. Yeung CK, Lam LK, Chan HH (2005) The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Exp Dermatol 30(5):600-602